Saturday, November 20, 2021

FDA approves high-tech sound wave surgery for common Parkinson’s symptoms


 News Release 17-Nov-202
Focused ultrasound interrupts faulty brain circuits without need to cut into skull
Business Announcement
University of Virginia Health System


The federal Food and Drug Administration has approved an incisionless form of brain surgery to treat advanced Parkinson’s disease after successful testing at the University of Virginia School of Medicine and other sites.

The authorization allows the use of Insightec’s Exablate Neuro focused ultrasound device to treat problems with mobility, rigidity and involuntary movements known as dyskinesias that are common in Parkinson’s. UVA is one of only 37 medical centers in the country with the capacity to offer this minimally invasive treatment, according to the Charlottesville-based Focused Ultrasound Foundation, a longtime supporter of UVA’s pioneering research into the many potential applications of the technology.



No comments:

Post a Comment